Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global Smart Medical Devices Market (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts

Published

on

Dublin, April 12, 2022 (GLOBE NEWSWIRE) — The “Smart Medical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global smart medical devices market reached a value of US$ 36.92 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 58.58 Billion by 2027 exhibiting a CAGR of 7.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Smart medical devices are wireless electronic instruments intended to monitor patients’ health by collecting and communicating real-time updates. Insulin pumps, heart rate monitors, pulse oximeters, portable oxygen concentrators and blood pressure monitors are some of the commonly used smart medical devices. These devices are usually operated on a wireless network like wi-fi, Bluetooth, and various technologies and are widely used to monitor, analyze and transmit patient’s critical data. Smart medical devices provide a high level of mobility, ability to monitor patient status remotely. They also assist in reducing workload, saving time, increasing patient engagement and control, reducing errors, improving communication, and enhancing safety. As a result, smart medical devices are widely used in hospitals, clinics and home care settings.

Smart Medical Devices Market Trends:

Significant growth in the healthcare industry across the globe is one of the key factors creating a positive outlook of the market. The increasing prevalence of chronic medical ailments, such as asthma, diabetes, blood pressure and chronic obstructive pulmonary disease (COPD), has facilitated the usage of these devices across various healthcare settings. Additionally, the widespread adoption of smart wearable medical devices due to the rising health consciousness among the masses is favoring the market growth.

Moreover, various technological advancements, such as the integration of artificial intelligence (AI), Internet of Things (IoT) and machine-to-machine technology, are providing a thrust to market growth. These technologies offer greater precision, ensure accurate storing and monitoring of patient information, and enhance the overall user experience.

Advertisement
Stake.com

In line with this, the increasing product demand in home care settings due to the sudden outbreak of coronavirus disease (COVID-19) for disease management, monitoring, providing feedback and suggesting adequate treatment is positively impacting the market growth. Other factors, including rising expenditure capacity of consumers, rising geriatric population, along with the implementation of various government initiatives to spread awareness about disease prevention, are anticipated to drive the market toward growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global smart medical devices market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, distribution channel, application and end user.

Breakup by Product Type:

  • Diagnostic and Monitoring
  • Blood Glucose Monitors
  • Heart Rate Monitors
  • Pulse Oximeters
  • Blood Pressure Monitors
  • Breath Analyzer
  • Other Diagnostic Monitoring Products
  • Therapeutic Devices
  • Portable Oxygen Concentrators and Ventilators
  • Insulin Pumps
  • Hearing Aid
  • Other Therapeutic Devices

Breakup by Distribution Channel:

  • Pharmacies
  • Online
  • Others

Breakup by Application:

  • Oncology
  • Diabetes
  • Auto-Immune Disorders
  • Infectious Diseases
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Home-Care Setting
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Activinsights Ltd, Apple Inc., Debiotech SA, Enable Injections, Fitbit LLC (Google LLC), Koninklijke Philips N.V., Medtronic PLC, NeuroMetrix Inc., Omron Healthcare Co Ltd (Omron Corporation), Sonova Holding AG, Sotera Wireless Inc. and VitalConnect.

Advertisement
Stake.com

Key Questions Answered in This Report:

  • How has the global smart medical devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global smart medical devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global smart medical devices market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

Advertisement
Stake.com

5 Global Smart Medical Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Diagnostic and Monitoring
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Blood Glucose Monitors
6.1.2.2 Heart Rate Monitors
6.1.2.3 Pulse Oximeters
6.1.2.4 Blood Pressure Monitors
6.1.2.5 Breath Analyzer
6.1.2.6 Other Diagnostic Monitoring Products
6.1.3 Market Forecast
6.2 Therapeutic Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Portable Oxygen Concentrators and Ventilators
6.2.2.2 Insulin Pumps
6.2.2.3 Hearing Aid
6.2.2.4 Other Therapeutic Devices
6.2.3 Market Forecast

7 Market Breakup by Distribution Channel
7.1 Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Online
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Application
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diabetes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Auto-Immune Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Infectious Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Home-Care Setting
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast

Advertisement
Stake.com

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

Advertisement
Stake.com

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Activinsights Ltd
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Apple Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Debiotech SA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Enable Injections
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Fitbit LLC (Google LLC)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Koninklijke Philips N.V.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Medtronic PLC
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 NeuroMetrix Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Omron Healthcare Co Ltd (Omron Corporation)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 SWOT Analysis
15.3.11 Sonova Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Sotera Wireless Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.13 VitalConnect
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio

For more information about this report visit https://www.researchandmarkets.com/r/trsjaj

Attachment


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

APIX and RBI Join Forces to Drive Financial Innovation Through HaRBInger 2024 Hackathon

Published

on

apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon

SINGAPORE, June 21, 2024 /PRNewswire/ — APIX, the leading global collaborative innovation platform for financial institutions and fintechs across over 90 countries, today announced its partnership with the Reserve Bank of India (RBI) to host the prestigious HaRBInger 2024 hackathon. This landmark collaboration aims to bring together the brightest minds from around the world to develop cutting-edge solutions that enhance the security and inclusivity of the financial ecosystem.

Under the overarching themes of Combatting Fraud and Financial Inclusion for the Differently-abled, the hackathon challenges participants to tackle four critical problem statements focused on real-time fraud detection, ensuring transaction anonymity, identifying mule accounts, and empowering the visually impaired in financial transactions.
“At APIX Platform, we are thrilled and proud to once again partner with Reserve Bank of India (RBI) for HaRBInger,” shares Umang Moondra, CEO of APIX. “Reserve Bank of India (RBI) has led from the front in driving innovation in the financial services sector, and HaBRInger 2024’s focus on critical challenges related to fostering security, integrity, transparency, trust and inclusivity in digital transactions, is a testament to the leadership role that they play.”
As a trusted platform utilised by major banks and regulators worldwide, APIX is uniquely positioned to empower innovators and accelerate their journey toward bringing innovative ideas to life. Leveraging innovative technologies such as AI/ML, APIs, Data Analytics, and more, HaRBInger 2024 participants will have the opportunity to create solutions that drive meaningful change and leave a lasting impact on the financial services industry.
The hackathon welcomes individuals, teams, and enterprises from diverse backgrounds and geographies to participate, offering a platform to showcase their skills on a global stage. With exciting prizes up for grabs, including INR 40,00,000 (~USD 48,000) for the winner in each problem statement category and a special prize of INR 20,00,000 (~USD 24,000) for the best all-woman team, the opportunities are substantial.
Registration for HaRBInger 2024 started on June 7, 2024, and will unfold in four exciting phases on the APIX Platform: screening of entries, shortlisting for solution development, solution development with mentoring and support, and the selection of winners.
Don’t miss this opportunity to collaborate with like-minded innovators, gain exposure to industry leaders, and shape the future of finance on the APIX Platform.
For media inquiries or additional details about HaRBInger 2024, please contact [email protected].
For more information and to register now, visit HaRBInger 2024 at: https://hackolosseum.apixplatform.com/h1/harbinger2024
About APIX:
APIX is a collaborative innovation platform for fintechs and innovators across 90+ countries, empowering Financial Institutions to accelerate their innovation journey. 
Major banks, insurers, and regulators in the world use APIX to rapidly discover, test, and evaluate solutions by running comprehensive innovation programs, which include innovation challenges and hackathons. 
Ideas are everywhere. Bring the best to the table with APIX. Collaborate to innovate today at www.apixplatform.com.  
Logo – https://mma.prnewswire.com/media/2443613/4773081/01_LOGO_COLOR_WITH_BLACK__MAIN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon-302178678.html

Continue Reading

Artificial Intelligence

Maxterial Raises nearly $8 Million in Series A Funding

Published

on

maxterial-raises-nearly-$8-million-in-series-a-funding

Reinforces Position as a Disruptive Force in Material Science Innovation

PLEASANTON, Calif., June 20, 2024 /PRNewswire/ — Maxterial, a technology company dedicated to pioneering advancements in material science including the commercialization of advanced coatings, has announced the successful closure of its Series A funding round, raising nearly $8 million. This milestone underscores Maxterial’s rising influence in disruptive material science technologies and its commitment to reshaping traditional industry norms with dynamic and environmentally responsible solutions.
Led by CEO Dr. Mehdi Kargar and Chief Technology Officer Dr. Amy Haghdoost, Maxterial has pioneered material science advancements for nearly a decade. The company’s lean approach to reaching the product-growth fit stage has garnered widespread acclaim, attracting a range of customers and influential investors, including Peter Thiel’s Breakout Labs, Pierre Omidyar’s UP2398, and corporate innovation leaders like Saint-Gobain and Anglo American.
The Series A funding round, led by Helios Climate Ventures, with participation from global corporation QEMETICA (formerly Ciech), solidifies Maxterial’s position as a leader in climate-conscious innovation. This capital enables Maxterial to accelerate its R&D efforts, including large-scale trials, expand its products, and scale operations in North America and Europe.
“We are thrilled to have secured nearly $11 million to date in equity financing, which reflects the confidence investors have in our vision, our unique go-to-market strategies, and the transformative potential of our technology,” said Dr. Mehdi Kargar, CEO of Maxterial. “This scalable platform fits many markets in urgent need of dynamic, sustainable solutions. Series A funding enables us to drive transformational growth across multiple industries.”
Maxterial replaces environmentally harmful and energy-inefficient processes using Hexavalent Hard Chrome (H-Chrome) with a superior solution that is safe, environmentally friendly, and cost effective at a time when material science startups have struggled to attract investment. The company breaks those cycles by delivering unique synergies that integrate the needs of investors, customers, supply chains, and industry experts with a product and service model that delivers exceptional performance, accelerates change and mitigates risk.
Maxterial has already gained significant initial traction. Ongoing trials in Europe and North America are attracting early adopters eager for cutting-edge solutions. By prioritizing sustainability, performance, and scalability, Maxterial can protect against wear, heat, and corrosion, reduce carbon footprint, and eliminate toxic materials like hexavalent chromium.
“We set out to create a company that delivers exceptional technology and exceptional returns,” notes Dr. Kargar. “As we accelerate our implementation, we want to share our insights and expertise with fellow entrepreneurs, industry leaders, and investors interested in driving positive change.”
For media inquiries, please contact:
Carmen FerrignoChief Marketing Officer, MaxterialPhone: 215.287.3658Email: [email protected]
About Maxterial:Maxterial is a Bay Area technology company dedicated to pioneering advancements in material science, including the commercialization of advanced coatings. Founded in 2015, Maxterial leverages an eco-systemic lean tech approach to develop innovative solutions that protect against wear, heat, and corrosion while reducing carbon footprint and eliminating toxic materials from industrial processes. Maxterial is committed to driving responsible transformation in the material science industry through thought leadership, innovation, and collaboration that inspires others to embrace responsible innovation.
To learn more, visit Maxterial.com
Logo – https://mma.prnewswire.com/media/2440672/Maxterial__Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/maxterial-raises-nearly-8-million-in-series-a-funding-302177099.html

Continue Reading

Artificial Intelligence

Altair Named a Leader in the June 2024 Gartner® Magic Quadrant™ for Data Science and Machine Learning Platforms

Published

on

altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant™-for-data-science-and-machine-learning-platforms

Altair recognized in the report’s Leaders’ Quadrant for Completeness of Vision and Ability to Execute
TROY, Mich., June 20, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, today announced that it has been positioned by Gartner as a Leader in the Magic Quadrant for Data Science and Machine Learning Platforms for its offering, Altair® RapidMiner®. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute.

According to the report, “Leaders in this market have a mature, refined, and targeted company and platform strategy that incorporates and leverages generative AI (GenAI) to drive their customers’ business value. They see opportunities for leveraging GenAI that other providers may not see or have made significant investments above and beyond standard offerings. They have the capability to innovate at a speed that outperforms other vendors. In addition, they can clearly articulate how they provide value to the multiple types of personas involved in the process of building data science and machine learning models.” 
“We believe being named as a Leader in this latest report validates what we have known for years: Altair has one of the market’s most unique, most comprehensive offerings for data analytics and machine learning,” said James R. Scapa, founder and chief executive officer, Altair. “For us, this placement is also a testament to our unmatched vision, which has defined us since our inception. We are pioneers that define what it means to be at the forefront of technological innovation and computational intelligence. I am incredibly proud of where Altair stands today, and I look forward to the strides we continue to make each day.”
Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables you to get the most from market analysis in alignment with your unique business and technology needs.
View a complimentary copy of the Magic Quadrant report to learn more about Altair’s strengths and cautions, among other provider offerings, at https://web.altair.com/gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-2024.
Gartner Disclaimer
Gartner, Magic Quadrant for Data Science and Machine Learning Platforms, Afraz Jaffri, Aura Popa, Peter Krensky, Jim Hare, Raghvender Bhati, Maryam Hassanlou, Tong Zhang, 17 June 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Altair
Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.
Media contacts
Altair Corporate                                           
Altair Investor Relations
Bridget Hagan                                             
Stephen Palmtag
+1.216.769.2658                                         
+1.669.328.9111
[email protected]                       
[email protected]
Altair Europe/The Middle East/Africa
Charlotte Hartmann
+49 7031 6208 0
[email protected]
 
Photo – https://mma.prnewswire.com/media/2444041/Altair_Newsroom_NR_Gartner_MQ_Social__2.jpg
Logo – https://mma.prnewswire.com/media/1421069/Altair_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-302178198.html

Continue Reading

Trending